File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Recurrence of duodenal ulcer after medical treatment

TitleRecurrence of duodenal ulcer after medical treatment
Authors
Lane, MRLee, SP
Issue Date1988
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet
Citation
Lancet, 1988, v. 1 n. 8595, p. 1147-1149 How to Cite?
Abstract562 patients whose duodenal ulcers had healed in a series of double-blind controlled trials of various medical treatments were enrolled in a long-term endoscopic follow-up. 436 were followed for up to four years or until relapse. Relapse rates did not differ between the groups treated with cimetidine, ranitidine, pirenzepine, or placebo. At six and twelve months but not subsequently, there was a significant advantage for tripotassium dicitrato-bismuthate. Relapse rates were at all times higher in smokers than in non-smokers.
Persistent Identifierhttp://hdl.handle.net/10722/175652
ISSN
0140-6736
2023 Impact Factor: 98.4
2023 SCImago Journal Rankings: 12.113
ISI Accession Number ID
WOS:A1988N453200012

 

DC FieldValueLanguage
dc.contributor.authorLane, MRen_US
dc.contributor.authorLee, SPen_US
dc.date.accessioned2012-11-26T09:00:17Z-
dc.date.available2012-11-26T09:00:17Z-
dc.date.issued1988en_US
dc.identifier.citationLancet, 1988, v. 1 n. 8595, p. 1147-1149en_US
dc.identifier.issn0140-6736en_US
dc.identifier.urihttp://hdl.handle.net/10722/175652-
dc.description.abstract562 patients whose duodenal ulcers had healed in a series of double-blind controlled trials of various medical treatments were enrolled in a long-term endoscopic follow-up. 436 were followed for up to four years or until relapse. Relapse rates did not differ between the groups treated with cimetidine, ranitidine, pirenzepine, or placebo. At six and twelve months but not subsequently, there was a significant advantage for tripotassium dicitrato-bismuthate. Relapse rates were at all times higher in smokers than in non-smokers.en_US
dc.languageengen_US
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lanceten_US
dc.relation.ispartofLanceten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAnti-Ulcer Agents - Therapeutic Useen_US
dc.subject.meshCimetidine - Therapeutic Useen_US
dc.subject.meshClinical Trials As Topicen_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshDuodenal Ulcer - Drug Therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshOrganometallic Compounds - Therapeutic Useen_US
dc.subject.meshPirenzepine - Therapeutic Useen_US
dc.subject.meshRanitidine - Therapeutic Useen_US
dc.subject.meshRecurrenceen_US
dc.subject.meshSmokingen_US
dc.subject.meshSucralfate - Therapeutic Useen_US
dc.titleRecurrence of duodenal ulcer after medical treatmenten_US
dc.typeArticleen_US
dc.identifier.emailLee, SP: sumlee@hku.hken_US
dc.identifier.authorityLee, SP=rp01351en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid2896967-
dc.identifier.scopuseid_2-s2.0-0023937148en_US
dc.identifier.volume1en_US
dc.identifier.issue8595en_US
dc.identifier.spage1147en_US
dc.identifier.epage1149en_US
dc.identifier.isiWOS:A1988N453200012-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridLane, MR=7401977312en_US
dc.identifier.scopusauthoridLee, SP=7601417497en_US
dc.identifier.issnl0140-6736-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats